Therapeutic Response to Tumor Necrosis Factor-alpha (TNF-alpha) Antagonists in Rheumatoid Arthritis.

NCT05379049 · clinicaltrials.gov ↗

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Rheumatoid Arthritis
Inflammatory Arthritis
Ankylosing Spondylitis

Interventions

BIOLOGICAL: Infliximab: Adalimumab; Etanercept;

Sponsor

University of Sulaimani